Research Topics
| Geary W OlsenSummaryAffiliation: St. Paul Country: USA Publications
| Collaborators
|
Detail Information
Publications
A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humansGeary W Olsen
Medical Department, 3M Company, St Paul, MN 55144 1000, USA
Toxicology 256:65-74. 2009..Thus, compared to PFOS and PFHxS, PFBS has a much lower potential for accumulation in human serum after repeated occupational, non-occupational (e.g., consumer), or environmental exposures...
Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010Geary W Olsen
3M Company, Medical Department, St Paul, Minnesota, United States
Environ Sci Technol 46:6330-8. 2012..8 years reported in individuals. This similarity supports the conclusion that the dominant PFOS-related exposures to humans in the United States were greatly mitigated during the phase-out period...
Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006Geary W Olsen
3M Company, Medical Department, St Paul, Minnesota, American Red Cross, North Central Region, St Paul, Minnesota, USA
Environ Sci Technol 42:4989-95. 2008..Direct and indirect exposure sources of PFOA could include historic and ongoing electrochemical cell fluorination (ECF) of PFOA, telomer production of PFOA, fluorotelomer-based precursors, and other fluoropoly-mer production...
Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking waterShu Ching Chang
Medical Department, 3M Company, St Paul, Minnesota 55144, USA
Toxicol Sci 104:40-53. 2008..These findings demonstrate that PFBA is eliminated efficiently from serum with a low potential for accumulation from repeated exposure...
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workersGeary W Olsen
Medical Department, 3M Company, St Paul, Minnesota 55144, USA
Environ Health Perspect 115:1298-305. 2007..The presence of perfluorooctanesulfonate (PFOS), perfluorohexanesulfonate (PFHS), and perfluorooctanoate (PFOA) has been reported in humans and wildlife. Pharmacokinetic differences have been observed in laboratory animals...
Analysis of a homologous series of perfluorocarboxylates from American Red Cross adult blood donors, 2000-2001 and 2006Geary W Olsen
Medical Department, 3M Company, St Paul, Minnesota, United States
Environ Sci Technol 45:8022-9. 2011..3 vs 0.5. Important observations were the decline in PFBA and increase in PFNA, PFDA, and PFUnA concentrations between 2000-2001 and 2006. The longer chain length perfluorocarboxylates were also highly correlated with each other...
Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facilityGeary W Olsen
3M Medical Company, Medical Department, St Paul, Minnesota 55144, USA
J Occup Environ Med 46:837-46. 2004..Non-a priori associations among the fluorochemical plant workers included benign colon polyps, malignant colorectal tumors, and malignant melanoma...
Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human bloodGeary W Olsen
Medical Department, 3M Company, Mail Stop 220 6W 08, St Paul, MN 55144, USA
Environ Health Perspect 113:539-45. 2005..Comparison with other regional data collected in 2001 did not suggest a continued increase in concentrations since 1989...
Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectivesGeary W Olsen
Medical Department, 3M Company, St Paul, MN 55144, USA
Reprod Toxicol 27:212-30. 2009..Important issues are addressed regarding the methods and data analysis that may limit inferences from this particular study...
Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donorsGeary W Olsen
3M Company, Medical Department, St Paul, MN 55144, USA
Chemosphere 68:105-11. 2007..0001). The decrease was consistent across donors' age and sex. To confirm these preliminary findings, additional sub-sets of year 2000 samples will be analyzed, and a much larger biomonitoring study of other locations is planned...
Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, WashingtonGeary W Olsen
Medical Department, 3M Company, Mail Stop 220 3W 05, St Paul, MN 55144, USA
Chemosphere 54:1599-611. 2004..Similar to other reported findings of younger adults, the geometric mean serum PFOS concentration in non-occupational adult populations likely approximates 30-40 ppb with 95% of the population's serum PFOS concentrations below 100 ppb...
Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workersGeary W Olsen
Medical Department, 3M Company, Mail Stop 220 6W 08, St Paul, MN 55144, USA
Int Arch Occup Environ Health 81:231-46. 2007..The purpose of this assessment was to examine this association in male workers who manufactured or used PFOA at three facilities...
Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley ratsJohn L Butenhoff
3M Company, Medical Department, 3M Center 220 06 W 08, Saint Paul, MN 55144, USA
Toxicology 298:1-13. 2012..All other tumor types were those seen spontaneously in rats of this stock and age and were not associated with feeding of APFO...
Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractionsJohn L Butenhoff
Medical Department, 3M Company, St Paul, MN 55455, USA
Toxicol Lett 210:360-5. 2012..These data do not support a strong role for plasma lipoprotein fractions in explaining the inconsistent dose-response associations reported in cross-sectional epidemiological studies...
Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicalsDavid J Ehresman
Medical Department, 3M Company, Mail Stop 220 6W 08, St Paul, MN 55144 1000, USA
Environ Res 103:176-84. 2007..The difference between plasma and serum and whole blood corresponded to volume displacement by red blood cells, suggesting that the fluorochemicals are not found intracellularly or attached to the red blood cells...
Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley ratsJohn L Butenhoff
Medical Department, 3M Company, Saint Paul, MN 55144, USA
Toxicology 293:1-15. 2012..Recent mechanistic studies suggest a PPARα/CAR/PXR-mediated mode of action for the liver tumors observed in the present two-year study...
Characterization of risk for general population exposure to perfluorooctanoateJohn L Butenhoff
Medical Department, 3M Company, Building 220 2E 02, St Paul, MN 55144, USA
Regul Toxicol Pharmacol 39:363-80. 2004..These MOE values represent substantial protection of children, adults, and the elderly...
The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuumJohn L Butenhoff
3M Company, Medical Department, St. Paul, Minnesota 55144, USA
Environ Health Perspect 114:1776-82. 2006....
Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donorsGeary W Olsen
Medical Department, 3M Company, St Paul, Minnesota 55144, USA
Environ Health Perspect 111:1892-901. 2003..Because serum PFOS concentrations correlate with cumulative human exposure, this information can be useful for risk characterization...
Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilitiesGeary W Olsen
Medical Department, 3M Company, St Paul, MN 55144, USA
J Occup Environ Med 54:974-83. 2012..To examine in a longitudinal occupational assessment whether changes in serum concentrations of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS) are associated with changes in non-high-density lipoprotein (HDL) cholesterol...
Cohort mortality study of roofing granule mine and mill workers. Part II. Epidemiologic analysis, 1945-2004Geary W Olsen
Medical Department, 3M Company, Mail Stop 220 6W 08, St Paul, MN 55144 1000, USA
J Occup Environ Hyg 9:257-68. 2012..76, 95% CI 1.01-2.86). This exposure-response trend was suggestive but imprecise. The study results are consistent with other cohorts with similar levels of exposure to respirable crystalline silica...
Worksite influenza immunization programs. Insight into the implementation and cost-benefitGeary W Olsen
3M Company, St. Paul, MN, USA
AAOHN J 53:105-10. 2005..Efficient large worksite influenza immunization programs are feasible and worthy of employer consideration for economic and employee satisfaction reasons...
An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoringGeary W Olsen
Medical Department, 3M Co, St. Paul, MN 55144, USA
AIHA J (Fairfax, Va) 64:651-9. 2003..098); perfluorooctanesulfonamide 0.013 (0.009-0.018); and perfluorooctanesulfonamidoacetate 0.022 (0.018-0.029). These geometric means were approximately one order of magnitude higher than those observed for the film plant employees...
